Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CBER
Fierce Biotech
Former FDA official Peter Marks joins Eli Lilly
Six months after his departure from the federal government, Peter Marks, M.D., Ph.D., has joined Eli Lilly.
Darren Incorvaia
,
Eric Sagonowsky
Oct 7, 2025 3:49pm
FDA targets Big Pharma in deluge of marketing letters
Sep 16, 2025 1:55pm
AstraZeneca TV spot for at-home FluMist lands in FDA crosshairs
Sep 16, 2025 11:07am
Vinay Prasad is back at the FDA after last month's surprise ouster
Aug 9, 2025 12:22pm
Prasad exit signals more permissive FDA for cell and gene field
Jul 31, 2025 9:10am
FDA taps new CDER chief as acting CBER head after Prasad exit
Jul 30, 2025 1:10pm